Westfield Capital Management
MRTX

Westfield Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Westfield Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-293,148
Closed -$43M – 267
2021
Q4 		$43M Buy
+293,148
New +$43M 0.26% 129